These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3488895)

  • 1. Bacteroides fragilis: current susceptibilities, mechanisms of drug resistance, and principles of antimicrobial therapy.
    Cuchural GJ; Tally FP
    Drug Intell Clin Pharm; 1986; 20(7-8):567-73. PubMed ID: 3488895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility vs. in vivo efficacy of various antimicrobial agents against the Bacteroides fragilis group.
    Brook I
    Rev Infect Dis; 1991; 13(6):1170-80. PubMed ID: 1775850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns.
    Aldridge KE; Ashcraft D; O'Brien M; Sanders CV
    Antimicrob Agents Chemother; 2003 Jan; 47(1):148-53. PubMed ID: 12499183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy.
    Tally FP; Cuchural GJ; Malamy MH
    Rev Infect Dis; 1984; 6 Suppl 1():S260-9. PubMed ID: 6326243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.
    García-Rodríguez JE; García-Sánchez JE
    Rev Infect Dis; 1990; 12 Suppl 2():S142-51. PubMed ID: 2305180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and susceptibility of resistant Bacteroides fragilis group organisms to new beta-lactam antibiotics.
    Heseltine PN; Appleman MD; Leedom JM
    Rev Infect Dis; 1984; 6 Suppl 1():S254-9. PubMed ID: 6585882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
    Brook I; Coolbaugh JC; Walker RI; Weiss E
    Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.
    Cuchural GJ; Tally FP; Jacobus NV; Gorbach SL; Aldridge K; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP
    Antimicrob Agents Chemother; 1984 Aug; 26(2):145-8. PubMed ID: 6486758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of the Bacteroides fragilis group in the United States in 1981.
    Tally FP; Cuchural GJ; Jacobus NV; Gorbach SL; Aldridge KE; Cleary TJ; Finegold SM; Hill GB; Iannini PB; McCloskey RV; O'Keefe JP; Pierson CL
    Antimicrob Agents Chemother; 1983 Apr; 23(4):536-40. PubMed ID: 6859833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
    Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y
    Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007-2020.
    Wu PH; Chen CH; Lin HH; Tseng KH; Ko WC; Ho MW; Hsueh PR
    Int J Antimicrob Agents; 2023 Jul; 62(1):106822. PubMed ID: 37088437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.
    Aldridge KE; Henderberg A; Sanders CV
    J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of carbapenem resistance in Bacteroides fragilis in China.
    Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
    Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
    Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
    Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
    Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
    Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
    Betriu C; Sánchez A; Gómez M; Palau ML; Picazo JJ
    J Antimicrob Chemother; 1999 Jan; 43(1):133-6. PubMed ID: 10381111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group.
    Fang H; Edlund C; Hedberg M; Nord CE
    Int J Antimicrob Agents; 2002 May; 19(5):361-70. PubMed ID: 12007843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
    Sydenham TV; Jensen BH; Petersen AM; Krogfelt KA; Justesen US
    Int J Antimicrob Agents; 2017 May; 49(5):573-578. PubMed ID: 28366659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.